Lam Research Corporation (LRCX)
Lam Research Max Pain By Strike
LRCX trades at $99.78, 17.4% above the near-term max pain of $85 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($55-$101), indicating stable market expectations. Key magnetic zone at 90 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Lam Research Max Pain By Expiry
Max pain for LRCX shows stable levels around 89.25, reflecting balanced market expectations. The 52% spread signals divergent expectations across timeframes. Most levels below 99.78 may cap rallies. Strong magnetic level at 90 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 85 | -14.78 (-14.82%) |
| Aug 22, 2025 | 101 | 1.22 (1.22%) |
| Aug 29, 2025 | 101 | 1.22 (1.22%) |
| Sep 5, 2025 | 100 | 0.22 (0.22%) |
| Sep 12, 2025 | 101 | 1.22 (1.22%) |
| Sep 19, 2025 | 84 | -15.78 (-15.82%) |
| Sep 26, 2025 | 95 | -4.78 (-4.80%) |
| Oct 17, 2025 | 55 | -44.78 (-44.88%) |
| Dec 19, 2025 | 95 | -4.78 (-4.80%) |
| Jan 16, 2026 | 86 | -13.78 (-13.81%) |
| Feb 20, 2026 | 90 | -9.78 (-9.81%) |
| Mar 20, 2026 | 90 | -9.78 (-9.81%) |
| Jun 18, 2026 | 95 | -4.78 (-4.80%) |
| Sep 18, 2026 | 90 | -9.78 (-9.81%) |
| Dec 18, 2026 | 82 | -17.78 (-17.82%) |
| Jan 15, 2027 | 78 | -21.78 (-21.83%) |